Global Dementia Drugs Market

Table of Content

1. Introduction
   • Definition of Dementia Drugs Market
   • Scope of the Report
2. Methodology
   • Executive Summary
   • Market Overview
   • Market Definition and Segmentation
3. Market Dynamics
   • Drivers
   • Restraints
   • Opportunities
   • Porter's Five Forces Analysis
   • PESTEL Analysis
4. Dementia Drugs Market,By Indication
   • Lewy Body Dementia
   • Parkinsons Disease Dementia
   • Alzheimers Disease
   • Vascular Dementia
   • Other Indications
5. Dementia Drugs Market, By Drug Class
   • Cholinesterase Inhibitors
   • NMDA Antagonists and its Combination Drugs
6. Dementia Drugs Market, By Distribution Channel
   • Retail Pharmacies
   • Hospital Pharmacies
   • Online Pharmacies
7. Dementia Drugs Market, By Geography
   • North America
     • United States
     • Canada
   • Europe
     • United Kingdom
     • Germany
     • France
     • Spain
     • Italy
     • Rest of Europe
   • Asia-Pacific
     • China
     • Japan
     • India
     • South Korea
     • Australia
     • Rest of Asia-Pacific
   • Latin America
     • Brazil
     • Mexico
     • Rest of Latin America
   • Middle East & Africa
     • Saudi Arabia
     • United Arab Emirates
     • South Africa
     • Rest of Middle East & Africa
8. Competitive Landscape
9. Company Profiles
   • apotex inc.
     • Company Overview
     • Product Portfolio and Description
     • Key Highlights
     • Financial Overview
   • Aurobindo Pharma Ltd
   • Biogen Idec
   • Eisai
   • Eli Lilly and Company
   • Johnson & Johnson
   • Abbvie Inc
   • F. Hoffmann-La Roche AG
   • Teva Pharmaceutical Industries
   • Novartis AG
10. Conclusion and Future Outlook
11. Appendix
    • Research Methodology
    • About the Pharmanucleus

12. Disclaimer